To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program.

Hozzl · 2022-02-08T23:15:12Z

Explore the details of House Bill 6214 To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program. currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/8/2022, 11:15 PM

Congressional Summary of HR 6214

This bill requires Medicare Advantage (MA) plans to cover COVID-19 (i.e., coronavirus disease 2019) testing and related visits without cost-sharing during the public health emergency declared on January 31, 2020. MA plans are also prohibited from instituting prior authorization or other utilization management requirements with respect to coverage of such services.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6214

Bill HR 6214 is currently in the status of Bill Introduced since March 12, 2020. Bill HR 6214 was introduced during Congress 116 and was introduced to the House on March 12, 2020. Bill HR 6214's most recent activity was Referred to the Subcommittee on Health. as of March 12, 2020

Bipartisan Support of Bill HR 6214

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6214

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health

- Emergency medical services and trauma care

- Health care costs and insurance

- Health care coverage and access

- Health technology, devices, supplies

- Infectious and parasitic diseases

- Medical tests and diagnostic methods

- Medicare

Alternate Title(s) of Bill HR 6214

To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program.